0001104659-18-015618.txt : 20180307
0001104659-18-015618.hdr.sgml : 20180307
20180307181826
ACCESSION NUMBER: 0001104659-18-015618
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180307
FILED AS OF DATE: 20180307
DATE AS OF CHANGE: 20180307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laumas Sandeep
CENTRAL INDEX KEY: 0001721664
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38410
FILM NUMBER: 18674478
MAIL ADDRESS:
STREET 1: 8480 HONEYCUTT RD, SUITE 200
CITY: RALEIGH
STATE: NC
ZIP: 27615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001720893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821386754
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 EAST MAIN STREET
CITY: BRANFORD
STATE: CT
ZIP: 06405
BUSINESS PHONE: 203-643-8060
MAIL ADDRESS:
STREET 1: 780 EAST MAIN STREET
CITY: BRANFORD
STATE: CT
ZIP: 06405
3
1
a3.xml
3
X0206
3
2018-03-07
0
0001720893
BioXcel Therapeutics, Inc.
BTAI
0001721664
Laumas Sandeep
C/O BIOXCEL THERAPEUTICS, INC.
780 EAST MAIN STREET
BRANFORD
CT
06405
1
0
0
0
Stock Options
0.41
2027-08-23
Common Stock
86979
D
The shares underlying this stock option vest as follows: 29,151 shares shall vest on August 22, 2018, and 28,914 shares shall vest on each of August 22, 2019 and August 22, 2020.
/s/ Sandeep Laumas
2018-03-07